IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,928,000 | -12.8% | 836,518 | 0.0% | 0.74% | -2.8% |
| Q4 2021 | $15,969,000 | -22.6% | 836,518 | 0.0% | 0.76% | -29.1% |
| Q3 2021 | $20,629,000 | +17.4% | 836,518 | +23.9% | 1.07% | +37.0% |
| Q2 2021 | $17,568,000 | +20.2% | 675,160 | +46.2% | 0.78% | +29.0% |
| Q1 2021 | $14,621,000 | -18.0% | 461,811 | +20.2% | 0.60% | -20.9% |
| Q4 2020 | $17,823,000 | +40.6% | 384,117 | -0.2% | 0.76% | +21.5% |
| Q3 2020 | $12,672,000 | – | 384,938 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |